Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: A phase II clinical trial of the fondazione italiana linfomi

Autor: Claudia Cellini, Francesco Zaja, Annalisa Arcari, Stefano Volpetti, Angela Ferrari, Caterina Stelitano, Simone Ferrero, James Carmichael, Stefano Pileri, Gerardo Musuraca, Caterina Patti, Flavia Salvi, Manuela Ceccarelli, Renato Fanin, Barbara Botto, Michele Spina, Elisa Montechiarello, Anna Marina Liberati, Marco Ladetto, Antonella Ferranti, Daniela Drandi, Claudia Minotto
Přispěvatelé: Zaja, Francesco, Ferrero, Simone, Stelitano, Caterina, Ferrari, Angela, Salvi, Flavia, Arcari, Annalisa, Musuraca, Gerardo, Botto, Barbara, Spina, Michele, Cellini, Claudia, Patti, Caterina, Liberati, Anna M., Minotto, Claudia, Pileri, Stefano A., Ceccarelli, Manuela, Volpetti, Stefano, Ferranti, Antonella, Drandi, Daniela, Montechiarello, Elisa, Ladetto, Marco, Carmichael, Jame, Fanin, Renato
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Popis: In this past decade, new therapeutic approaches based on the use of rituximab, high-dose cytosine-arabinoside, and autologous stem cell transplantation (ASCT) have changed the paradigm of mantle cell lymphoma (MCL) treatment, significantly improving the quality and duration of response and
Databáze: OpenAIRE